OR16-06 A Novel Pathway Controlling Anticancer Drug Induced Immunogenic Necrosis In ERα Positive Cancer Cells

Disclosure: J. Zhu: None. S. Ghosh: None. D. Duraki: None. M. Boudreau: Other; Self; Patent on ErSO. M. Jabeen: None. C. Mao: None. B. Park: None. G. Cheng: None. E.R. Nelson: None. P.J. Hergenrother: Advisory Board Member; Self; System Oncology. Other; Self; Patent on ErSO. D.J. Shapiro: Other; Sel...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Junyao, Ghosh, Santanu, Duraki, Darjan, Boudreau, Matthew, Jabeen, Musarrat, Mao, Chengjian, Park, Ben Ho, Cheng, Georgina, Nelson, Erik Russell, Hergenrother, Paul J, Shapiro, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554699/
http://dx.doi.org/10.1210/jendso/bvad114.2198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554699/
http://dx.doi.org/10.1210/jendso/bvad114.2198

Ejemplares similares